NL-OMON40796招募中3 期
Addition of Tobramycin inhalation antibiotic treatment to standard IV antibiotic treatment for ventilator-associated pneumonia - Vaporise study
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients older than 18 years
- •admitted to these ICUs for 48 hours or more
- •with clinical suspicion of VAP.
- •VAP is diagnosed in patients with previous invasive Mechanical ventilation for 48 hours or more .;The clinical suspicion of pneumonia is based on the ATS criteria:
- •- new or progressive radiologic pulmonary infiltrate
- •Together with at least two of the following three criteria:
- •- temperature >38°C
- •- leukocytosis >12,000/mm3 or leucopenia <4,000/mm3
- •- purulent respiratory secretions
排除标准
- •patients with allergy to tobramycin; pregnancy; expected to die within 72
- •hours after enrollment
研究者
相似试验
进行中（未招募）
1 期
A study comparing Tobramycin Inhalation Powder (TIP) administered once daily continuously versus TIP administered BID in 28 day on / 28 day off cycles for the treatment of pulmonary Pseudomonas aeruginosa in patients with cystic fibrosisMedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: LLTClassification code 10021860Term: Infection Pseudomonas aeruginosaSystem Organ Class: 100000004862Cystic FibrosisEUCTR2016-004318-82-Outside-EU/EEAovartis Pharmaceuticals Corporation200
尚未招募
不适用
Inhalation of tobramycin for the patients with persistent respiratory infection by Psudomonas aeruginosaPersistent respiratory infection by Pseudomonas aeruginosaJPRN-UMIN000002893Kumamoto university hospital5
进行中（未招募）
不适用
asale Inhalation von Tobramycin mit dem Pari Sinus-Vernebler bei Patienten mit Mukoviszidose und Pseudomonasnachweis im Nasen-Nasennebenhöhlenbereich.Nasal inhalation of tobramycin by the Pari Sinus nebulizer in patients with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways. - tobra nasal CF pilotsubjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airwaysEUCTR2008-000164-17-DEniversity of Jena14
已完成
3 期
ong-term inhaled nebulized tobramycin in patients with non-cystic fibrosis bronchiectasis. A randomized placebo controlled trial. The BATTLE study Bronchiectasis And Tobramycin SoluTion InhaLation ThErapy.bronchiectasis10006436NL-OMON47248Medisch Centrum Alkmaar58
已完成
不适用
Tobramycin nebulisation with I-neb (TONI) study in children with cystic fibrosis: pharmacokinetics and safety'Cystic Fibrosis' en 'CF'100836241000401810024970NL-OMON39647Erasmus MC, Universitair Medisch Centrum Rotterdam24